Express Scripts Holding Company (NASDAQ:ESRX) issued an update on its FY17 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $6.95-7.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.97. Express Scripts Holding also updated its Q3 guidance to $1.88-1.92 EPS.

Express Scripts Holding Company (NASDAQ ESRX) traded down 0.08% during midday trading on Tuesday, hitting $62.56. 3,461,456 shares of the stock were exchanged. The company has a 50 day moving average price of $62.86 and a 200 day moving average price of $65.32. Express Scripts Holding Company has a one year low of $57.80 and a one year high of $79.24. The firm has a market capitalization of $37.13 billion, a price-to-earnings ratio of 11.34 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.42% and a return on equity of 25.64%. The business had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same quarter last year, the firm earned $1.57 EPS. Express Scripts Holding’s quarterly revenue was up .5% compared to the same quarter last year. Equities analysts anticipate that Express Scripts Holding Company will post $6.97 EPS for the current year.

Several research analysts recently weighed in on ESRX shares. ValuEngine lowered shares of Express Scripts Holding from a buy rating to a hold rating in a research note on Friday, June 2nd. Mizuho dropped their target price on shares of Express Scripts Holding from $76.00 to $61.00 and set a neutral rating on the stock in a report on Tuesday, April 25th. Evercore ISI dropped their target price on shares of Express Scripts Holding from $68.50 to $59.00 and set an in-line rating on the stock in a report on Wednesday, April 26th. Cowen and Company restated an outperform rating and set a $83.00 target price on shares of Express Scripts Holding in a report on Friday, June 9th. Finally, Edward Jones downgraded shares of Express Scripts Holding from a buy rating to a hold rating in a report on Wednesday, April 26th. Four research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of $71.89.

In other news, VP Phyllis S. Anderson sold 1,100 shares of the business’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the sale, the vice president now owns 11,108 shares of the company’s stock, valued at $667,368.64. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.68% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Express Scripts Holding Company (NASDAQ:ESRX) Updates FY17 Earnings Guidance” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/07/25/express-scripts-holding-company-nasdaqesrx-updates-fy17-earnings-guidance.html.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Earnings History and Estimates for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.